The retraction notice for the paper, “Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome,” fairly bristles with indignation:
The Editor-in-Chief, Dr Pilch, of Drug Design, Development and Therapy has been alerted to unacceptable levels of duplication between a previously published paper: Macciò A, Madeddu C, Mantovani G. Current pharmacotherapy options for cancer anorexia and cachexia. Expert Opin. Pharmacotherapy 2012 13(17) 2453–2472 and one published subsequently in Drug Design, Development and Therapy: Mantovani G, Madeddu C, Macciò A. Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome. Drug Design, Development and Therapy 2013:7 645–656.
Of course, duplication happens. But we wonder if this might have been avoidable with a little more work on the part of the folks at Dove. Then again, right on this now-retracted article’s page is a testimonial from a happy author:
“I was impressed at the rapidity of publication from submission to final acceptance.” Dr Edwin Thrower, PhD, Yale University.